Literature DB >> 3792855

A prognostic index for patients with malignant melanoma of the conjunctiva.

F H Stefani.   

Abstract

From 1968 to 1984, 31 patients with histologically proven malignant melanoma of the conjunctiva were treated and followed in the Eye Hospital of the University of München. Histological demonstration of tumor thickness and the mitotic index (number of mitoses per square millimeter) gave a the prognostic index, in which tumor thickness was multiplied by the mitotic index. This index then allowed evaluation of the risk for tumor metastasis. Most tumors measured less than 1.5 mm in thickness, and the metastatic risk was low or medium in these cases. All tumors of the low metastatic risk group had a prognostic index of 1 or less, while all recurrences were associated with a prognostic index that exceeded 1.

Entities:  

Mesh:

Year:  1986        PMID: 3792855     DOI: 10.1007/bf02154748

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Epibulbar tumors.

Authors:  J E ASH
Journal:  Am J Ophthalmol       Date:  1950-08       Impact factor: 5.258

2.  [Iris prolapse: excision or reposition? On the intraoperative prevention of epithelial implantation].

Authors:  F H Stefani
Journal:  Fortschr Ophthalmol       Date:  1984

3.  [Thermal epithelial abrasion in iris prolapse of long duration following cataract extraction].

Authors:  F Stefani
Journal:  Fortschr Ophthalmol       Date:  1985

Review 4.  Conjunctival melanoma.

Authors:  F A Jakobiec
Journal:  Arch Ophthalmol       Date:  1980-08

5.  Conjunctival melanomas: prognostic factors a review and an analysis of a series.

Authors:  J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  1980

6.  [Prognostic index in malignant melanoma. A better method to determine metastasis risk].

Authors:  C Schmoeckel; K K Nejad; O Braun-Falco
Journal:  Pathologe       Date:  1980-02       Impact factor: 1.011

7.  Malignant melanomas of the conjunctiva.

Authors:  V B Bernardino; M A Naidoff; W H Clark
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

8.  Cryotherapy for precancerous melanosis (atypical melanocytic hyperplasia) of the conjunctiva.

Authors:  S Brownstein; F A Jakobiec; R D Wilkinson; J Lombardo; W B Jackson
Journal:  Arch Ophthalmol       Date:  1981-07

9.  Malignant melanoma of the conjunctiva.

Authors:  R Folberg; I W McLean; L E Zimmerman
Journal:  Hum Pathol       Date:  1985-02       Impact factor: 3.466

10.  Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva.

Authors:  F A Jakobiec; S Brownstein; R D Wilkinson; M Khalil; W C Cooper; H R Shibata
Journal:  Arch Ophthalmol       Date:  1980-08
View more
  5 in total

1.  Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population.

Authors:  J C Norregaard; N Gerner; O A Jensen; J U Prause
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

2.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

Authors:  A D Paridaens; D C Minassian; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

4.  Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.

Authors:  P K Lommatzsch; R E Lommatzsch; I Kirsch; P Fuhrmann
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

5.  Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

Authors:  A D Paridaens; A C McCartney; D C Minassian; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.